Relative to type I IFNs and interleukins, CC and CXC chemokines were produced at high levels during infection by all SARS-CoV-2 strains in agreement with observations made in the lungs of humans infected with SARS-CoV-2 and suffering from severe COVID-19 [22,30]. This evidence concerns the gene CXCR1 and COVID-19.